These findings suggested a strong correlation between elevated Tim-1 expression in liver cancer, HSC activation, increased ECM, and the potential therapeutic impact of Tim-1 blockade on HCC progression. This evidence concerns the gene HAVCR1 and hepatocellular carcinoma.